| Reagan-Udall Foundation

Read more about Evaluation of Direct Antiviral Treatments Against SARS-CoV-2 in Immunocompromised Patients with Covid-19. a G2i Study, National Multicenter Observational and Retrospective from June 2023 to April 2024

Read more about Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Prevention of COVID-19-Associated Cytokine Storm

Read more about A Study of an Investigational Flu Seasonal/SARS-CoV-2 Combination Vaccine in Adults

Read more about Improving Health Status in COVID-19 Long-Hauler

Read more about A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

The Reagan-Udall Foundation for the FDA is leading an initiative to identify holistic approaches to address opportunities and challenges in animal health and veterinary medicine.

Coverage

Read more about American Association of Swine Veterinarians: Survey: Addressing Unmet Need Within the Animal and Veterinary Industries

In establishing the Hub, FDA gathered feedback from stakeholders through a public meeting, held on Oct. 16, 2024 in collaboration with the Reagan-Udall Foundation.

Coverage

Read more about Pharmaceutical Technology: FDA Rare Disease Innovation Moves Forward

Subscribe to

(202) 849 - 2075

1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036

admin@reaganudall.org

PDO Based Drug Sensitive Test in R/M HNSCC

PDO Based Drug Sensitive Test in R/M SGC

A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People

Evaluation of Direct Antiviral Treatments Against SARS-CoV-2 in Immunocompromised Patients with Covid-19. a G2i Study, National Multicenter Observational and Retrospective from June 2023 to April 2024

Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Prevention of COVID-19-Associated Cytokine Storm

A Study of an Investigational Flu Seasonal/SARS-CoV-2 Combination Vaccine in Adults

Improving Health Status in COVID-19 Long-Hauler

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

American Association of Swine Veterinarians: Survey: Addressing Unmet Need Within the Animal and Veterinary Industries

Pharmaceutical Technology: FDA Rare Disease Innovation Moves Forward

Subscribe for updates from the Reagan-Udall Foundation for the FDA